Results 21 to 30 of about 29,612 (275)
Glycosuria and Allied Conditions . By P. J. Cammidge, M.D.
The Indian medical gazette, 1913 work on the subject. Glycosuria is essentially a chemical problem and should primarily be attached from a chemical point of view. The book begins with a discussion of the properties and pli3'siology of the carbohydrates, and methods for their detection ...
J. J. R. Macleod
openalex +2 more sources
Diabetologia, 1971 An effect of insulin on glycosuria independent of its effect on blood sugar was demonstrated in a group of seven diabetics. To do this it was necessary to develop a technique in which the hypoglycaemic effect of insulin could be isolated and overcome.
G.S. Spathis
openaire +4 more sources
ALIMENTARY RENAL GLYCOSURIA [PDF]
Archives of Internal Medicine, 1918 INTRODUCTION The glucose content of normal human urine is under 0.1 per cent., usually merely a trace. The kidneys normally excrete urine containing a lower concentration of glucose than is found in the blood. When the kidneys show a higher permeability for glucose, sugar should appear in the urine while the tissues still retain the normal power of ...
Kingo Goto
openaire +3 more sources
A kidney-hypothalamus axis promotes compensatory glucose production in response to glycosuria. [PDF]
ElifeThe kidneys facilitate energy conservation through reabsorption of nutrients including glucose. Almost all the filtered blood glucose is reabsorbed by the kidneys.
Faniyan TS +8 more
europepmc +2 more sources
Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis [PDF]
Endocrinology and Metabolism, 2023 When sodium-glucose cotransporter-2 (SGLT2) inhibitors were first introduced a decade ago, no one expected them to have substantial effects beyond their known glucose-lowering effects, until the emergence of evidence of their robust renal and ...
Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung
doaj +1 more source
Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial. [PDF]
Diabetes, 2023 SGLT2 inhibitors have been shown to provide pronounced reductions in cardiorenal outcomes, including cardiovascular death, heart failure, and renal failure. The mechanisms underlying these benefits remain uncertain. We hypothesized that the effects could
Ferrannini E +6 more
europepmc +2 more sources
BMC Infectious Diseases, 2021 Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significant glycosuria and increased risk of genital mycotic infections (GMI ...
C. Bartolo +6 more
semanticscholar +1 more source